Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet.

22 May 2018

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer, potentially increasing life expectancy.

22 May 2018

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.

22 May 2018

DNA vaccine shows promise for colorectal cancer

For the first time in humans, researchers are testing a combined approach to treating advanced stage colorectal cancer (CRC) that may be life-changing for patients.

22 May 2018

Eczema drug alleviates asthma symptoms and improves lung function

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.

22 May 2018

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

21 May 2018

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Researchers from the Albert Einstein College of Medicine in New York have discovered that a signaling protein elevated in patients with acute myeloid leukemia plays a much wider role in the disease than previously thought.

18 May 2018

Study: Psoriasis patients taking Humira show no change in aortic inflammation

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation – a key marker of future risk of major cardiovascular events – unlike other antibodies that target different aspects of the immune system.

18 May 2018

Study finds body temperature as major barrier to potential dengue, Zika vaccine

A major route toward creating effective vaccines against dengue virus and Zika involves the E protein that covers the surface of each viral particle.

18 May 2018

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Dr. Robert Britton firmly believes every molecule is important. This chemist doesn't want any molecule sitting unused on a laboratory shelf or in a fridge.

18 May 2018

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.

17 May 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

Researchers discover a new antibody type

Researchers have made a discovery that contradicts previous understanding that an antibody only eliminates a specific subgroup of bacteria.

16 May 2018

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

The most severe allergic reaction, anaphylaxis, is the result of an inappropriate immune reaction following the introduction of a usually harmless antigen into the body.

16 May 2018

Immune system can produce 'universal antibodies' against various microorganisms

Bacteria and other microorganisms display structures from sugar molecules on their surfaces. These sugar structures play an important role for immune defense.

15 May 2018

Computer models provide valuable insight to structure and function of Ebola, Zika viruses

The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.

15 May 2018

Study: Antibodies against hemorrhagic fever disarm two viruses of same family

Hemorrhagic fever viruses, so named for their ability to induce massive, and at times fatal, internal bleeding, captured the world's attention during the Ebola outbreak of 2014-2016 in West Africa.

15 May 2018

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

New test developed for accurate and safe diagnosis of peanut allergies

Researchers from the School of Immunology & Microbial Sciences and the Medical Research Council have developed a new test to diagnose peanut allergy.

14 May 2018

Queen's University researchers receive MRC award to develop new treatment for pancreatic cancer

Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.

11 May 2018

Antibody News and Research

Further Reading

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

DNA vaccine shows promise for colorectal cancer

Eczema drug alleviates asthma symptoms and improves lung function

Scientists identify new drug target to combat chikungunya virus

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Study: Psoriasis patients taking Humira show no change in aortic inflammation

Study finds body temperature as major barrier to potential dengue, Zika vaccine

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Researchers discover a new antibody type

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

Immune system can produce 'universal antibodies' against various microorganisms

Computer models provide valuable insight to structure and function of Ebola, Zika viruses

Study: Antibodies against hemorrhagic fever disarm two viruses of same family

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

New test developed for accurate and safe diagnosis of peanut allergies

Queen's University researchers receive MRC award to develop new treatment for pancreatic cancer

How to make hybridoma-based antibody discovery more efficient eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo